Decipher score as a predictor of response to treatment intensification in the NRG Oncology-RTOG 0534 (SPPORT) phase III randomized post-prostatectomy salvage radiotherapy trial. Continuous MMAI scores ...

Oridis Biomed has announced that it has entered into a license agreement with the National Institutes of Health (NIH) for the worldwide commercial use of NIH's proprietary Tissue microarray (TMA) ...